EUR 114.00 For Business Accounts Only

MyoKardia Inc (MYOK) - Financial Analysis Review

MyoKardia Inc (MYOK) - Financial Analysis Review

Summary

MyoKardia Inc (MyoKardia) is a clinical stage biopharmaceutical company which discovers, develops and commercializes therapies for rare cardiovascular diseases. It primarily focuses on the treatment of heritable cardiomyopathies. The company’s pipeline portfolio includes MYK-461 is an orally administered small molecule which is designed to reduce left ventricular contractility by allosterically modulating the function of cardiac myosin and MYK-491 is used treat dilated cardiomyopathy (DCM).

GlobalData's MyoKardia Inc (MYOK) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

MyoKardia Inc Key Recent Developments:

Feb 01,2017: MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs
Dec 01,2016: MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer
Nov 07,2016: MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results
Aug 09,2016: MyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs
May 12,2016: MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.


Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.